NHS England
Buyer information published with procurement notices.
- Published identifier
- GB-PPON PDPT-3135-BWWY
- Address
- London, UKI45, SE1 8UG, United Kingdom
- First notice
- 30 Jan 2025
- Latest notice
- 19 Oct 2026
Published procurement activity · 1,377 tenders
Buyer information published with procurement notices.
This is a notice of intention to make an award in respect of the Most Suitable Provider (MSP) Process for the Hyperbaric Oxygen Therapy (HBOT) Services for all ages (Lot 1: North West and Lot 2: North East and Yorkshire). For the avoidance of doubt, this is an intention to award notice. A notice of the confirmation of the award
National Generic Pharmaceuticals – Project Revive DCE/DSW regions – 01/04/27 to 31/01/29 (22 months) DLS/DNE regions – 01/04/27 to 31/01/29 (22 months) DLN/DNW regions – 01/04/27 to 31/01/29 (22 months)
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU) on behalf of NHS England Midlands (The Commissioner) have awarded a contract to Vaccination UK Limited for the provision of Community and School Aged Immunisation Service (CSAIS) in Birmingham and Solihull.
This procurement activity is hosted by University Hospitals Birmingham NHS Foundation Trust (the “Authority”) on behalf of the NHS England, for the requirement of a Midlands Critical Care Transfer Services Ambulance Provider. This service covers the ambulance provider provision for the Midlands Critical Care Transfer Services (M
NHS England is inviting suppliers to participate in preliminary market engagement in relation to an upcoming procurement for the refresh and redesign of its flagship leadership development programmes: Edward Jenner, Mary Seacole and Rosalind Franklin. The objective of this engagement is to gather market intelligence and obtain s
Preliminary Market Engagement / Early Market Engagement NHS England is undertaking preliminary market engagement to inform three separate but connected requirements within the Targeted Prostate Cancer Screening Programme. The proposed workstreams are: 1. PSA laboratory processing and pathway support; 2. prostate MRI reporting; 3
Cancer in children and young people is rare and yet the biggest cause of premature death for children and young people aged 5-14 years . In the UK, around 2,000 children under 15 are diagnosed with cancer each year, with acute leukaemias and cancers of the brain and spinal cord being the most common types of childhood cancer. As
The Contracting Authority is procuring a targeted prostate cancer screening pathway with a focus on men at increased risk due to an inherited BRCA2 variant utilising the competitive provider selection process under the Health Care Services (Provider Selection Regime) Regulations 2023.<br/><br/>NHS England is seeking a provider t
Project title: NHS National Framework for Lenvatinib Offer reference number: CM/TNS/26/5751 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5751 Lenvatinib Lot 1 CESW: 01/06/2027 to 31/01/2029 (20 months) Lot 2
NHS England - East of England (referred to as the Commissioner) awarded a contract to Provide Community Interest Company for the Provision of Cervical Screening and Opportunistic Section 7a Immunisations in sexual health services across the East of England region (window 2) following a robust Competitive Process.
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.